menu search

OYST / OYSTER PT PHARM (OYST) Reports Q4 Loss, Tops Revenue Estimates

OYSTER PT PHARM (OYST) Reports Q4 Loss, Tops Revenue Estimates
OYSTER PT PHARM (OYST) delivered earnings and revenue surprises of -15.83% and 1,206.14%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock? Read More
Posted: Feb 24 2022, 20:46
Author Name: Zacks Investment Research
Views: 110781

OYST News  

Oyster Point Pharma To Report Second Quarter 2022 Financial Results On August 11, 2022

By GlobeNewsWire
August 8, 2022

Oyster Point Pharma To Report Second Quarter 2022 Financial Results On August 11, 2022

Conference Call and Webcast Scheduled for August 11, 2022, 4:30 p.m. ET more_horizontal

Oyster Therapeutics: State Of Business Is Confounding

By Seeking Alpha
June 30, 2022

Oyster Therapeutics: State Of Business Is Confounding

OYST has an approved product that is highly competitive against a blockbuster drug. They seem to have executed commercialization pretty well, except i more_horizontal

Oyster Point Pharma, Inc.'s (OYST) CEO Dr. Jeffrey Nau on Q1 2022 Results - Earnings Call Transcript

By Seeking Alpha
May 8, 2022

Oyster Point Pharma, Inc.'s (OYST) CEO Dr. Jeffrey Nau on Q1 2022 Results - Earnings Call Transcript

Oyster Point Pharma, Inc. (NASDAQ:OYST ) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants Arty Ahmed - Vice President, Inv more_horizontal

Oyster Point Pharma, Inc. (OYST) CEO Jeffrey Nau on Q4 2021 Results - Earnings Call Transcript

By Seeking Alpha
February 27, 2022

Oyster Point Pharma, Inc. (OYST) CEO Jeffrey Nau on Q4 2021 Results - Earnings Call Transcript

Oyster Point Pharma, Inc. (OYST) CEO Jeffrey Nau on Q4 2021 Results - Earnings Call Transcript more_horizontal

Oyster Point Pharma, Inc. (OYST) CEO Jeffrey Nau on Q4 2021 Results - Earnings Call Transcript

By Seeking Alpha
February 27, 2022

Oyster Point Pharma, Inc. (OYST) CEO Jeffrey Nau on Q4 2021 Results - Earnings Call Transcript

Oyster Point Pharma, Inc. (OYST) CEO Jeffrey Nau on Q4 2021 Results - Earnings Call Transcript more_horizontal

Oyster Point Pharma, Inc. (OYST) CEO Jeffrey Nau on Q4 2021 Results - Earnings Call Transcript

By Seeking Alpha
February 27, 2022

Oyster Point Pharma, Inc. (OYST) CEO Jeffrey Nau on Q4 2021 Results - Earnings Call Transcript

Oyster Point Pharma, Inc. (OYST) CEO Jeffrey Nau on Q4 2021 Results - Earnings Call Transcript more_horizontal

OYSTER PT PHARM (OYST) Reports Q4 Loss, Tops Revenue Estimates

By Zacks Investment Research
February 24, 2022

OYSTER PT PHARM (OYST) Reports Q4 Loss, Tops Revenue Estimates

OYSTER PT PHARM (OYST) delivered earnings and revenue surprises of -15.83% and 1,206.14%, respectively, for the quarter ended December 2021. Do the nu more_horizontal

OYSTER PT PHARM (OYST) Reports Q4 Loss, Tops Revenue Estimates

By Zacks Investment Research
February 24, 2022

OYSTER PT PHARM (OYST) Reports Q4 Loss, Tops Revenue Estimates

OYSTER PT PHARM (OYST) delivered earnings and revenue surprises of -15.83% and 1,206.14%, respectively, for the quarter ended December 2021. Do the nu more_horizontal


Search within

Pages Search Results: